The company's nucleic acid extraction kits have offered labs relief from COVID-19-related shortages of traditional silica-based bind-wash-elute assays.
Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand
If the lateral flow assay receives US regulatory approval, it would be the first antigen test for use in both symptomatic and asymptomatic individuals.
Roche Expects CE Mark for SARS-CoV-2 Rapid Antigen Test
The point-of-care test provides results in 15 minutes and can be used for both symptomatic and asymptomatic patients.
Visceral Leishmaniasis Tests Lack Accuracy, Study Finds
The study compared a variety of serological tests for visceral leishmaniasis that are available in Brazil, a hotspot for the parasitic disease.
Danaher to Buy GE Biopharma for $21.4B
Danaher is financing the deal with $3 billion from an equity offering, cash on hand, and proceeds from an issuance of debt and/or new credit facilities.